Institutional Ownership Trevi Therapeutics, Inc. (TRVI)
This table provides information about the institutional ownership of Trevi Therapeutics, Inc. (TRVI). We have compiled data on the 94 institutions that hold shares in the stock, with a total of 57.1 Million shares, which have been reported (via 13F filing form) to have a value of $159 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Nea Management Company, LLC
Timonium, MD |
Nov 14, 2024 Q3 2024 |
11,370,376
shares
|
$31.7 Million
2.9% of portfolio
|
Q1 2023
Reduced 0.02%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Nov 15, 2024 Q3 2024 |
7,381,090
shares
|
$20.6 Million
1.33% of portfolio
|
Q4 2023
Added 7.27%
|
|
|
Rubric Capital Management LP
New York, NY |
Nov 13, 2024 Q3 2024 |
5,026,931
shares
|
$14 Million
0.47% of portfolio
|
Q2 2024
Reduced 9.65%
|
|
|
Viking Global Investors LP
|
Nov 14, 2024 Q3 2024 |
4,400,000
shares
|
$12.3 Million
0.06% of portfolio
|
Q3 2022
New holding
|
|
|
Vr Adviser, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
3,422,656
shares
|
$9.55 Million
1.18% of portfolio
|
Q3 2024
Added 0.0%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
3,262,381
shares
|
$9.1 Million
0.0% of portfolio
|
Q3 2024
Added 33.84%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
3,135,115
shares
|
$8.75 Million
0.0% of portfolio
|
Q2 2024
Added 31.97%
|
|
|
Logos Global Management LP
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
2,750,000
shares
|
$7.67 Million
1.22% of portfolio
|
Q3 2024
Reduced 1.79%
|
|
|
Opaleye Management Inc.
Boston, MA |
Nov 14, 2024 Q3 2024 |
2,567,990
shares
|
$7.16 Million
1.57% of portfolio
|
Q3 2024
Reduced 2.91%
|
|
|
Vivo Capital, LLC
Palo Alto, CA |
Nov 13, 2024 Q3 2024 |
1,612,903
shares
|
$4.5 Million
0.79% of portfolio
|
Q3 2024
New holding
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
Nov 12, 2024 Q3 2024 |
1,538,517
shares
|
$4.29 Million
0.8% of portfolio
|
Q3 2024
Added 1.88%
|
|
|
Mai Capital Management
|
Nov 07, 2024 Q3 2024 |
1,327,285
shares
|
$3.7 Million
0.04% of portfolio
|
Q3 2024
Added 0.67%
|
|
|
Ally Bridge Group (Ny) LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
1,322,800
shares
|
$3.69 Million
3.14% of portfolio
|
Q3 2024
Reduced 10.31%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
1,264,166
shares
|
$3.53 Million
0.0% of portfolio
|
Q3 2024
Added 10.24%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
952,912
shares
|
$2.66 Million
0.0% of portfolio
|
Q3 2024
Added 5.9%
|
|
|
Woodline Partners LP
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
606,227
shares
|
$1.69 Million
0.02% of portfolio
|
Q3 2024
New holding
|
|
|
Silverarc Capital Management, LLC
|
Nov 14, 2024 Q3 2024 |
482,575
shares
|
$1.35 Million
0.4% of portfolio
|
Q3 2024
Reduced 42.84%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
433,642
shares
|
$1.21 Million
0.0% of portfolio
|
Q3 2024
Added 35.05%
|
|
|
Landscape Capital Management, L.L.C.
|
Nov 08, 2024 Q3 2024 |
424,725
shares
|
$1.18 Million
0.16% of portfolio
|
Q3 2024
Reduced 29.85%
|
|
|
Acuta Capital Partners, LLC
Belmont, CA |
Nov 14, 2024 Q3 2024 |
290,500
shares
|
$810,495
0.98% of portfolio
|
Q3 2024
Added 11.73%
|
|
|
Checkpoint Capital L.P.
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
250,000
shares
|
$697,500
0.41% of portfolio
|
Q3 2024
Reduced 50.01%
|
|
|
Tejara Capital LTD
London, X0 |
Nov 13, 2024 Q3 2024 |
241,613
shares
|
$674,100
0.38% of portfolio
|
Q3 2024
Reduced 40.49%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
198,480
shares
|
$553,759
0.0% of portfolio
|
Q3 2024
Added 123.06%
|
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Nov 14, 2024 Q3 2024 |
185,481
shares
|
$517,491
0.01% of portfolio
|
Q2 2024
Added 92.25%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
164,238
shares
|
$458,224
0.0% of portfolio
|
Q3 2024
Added 124.39%
|